(ANSA) - ROME, NOV 03 - Molecular swab for a suspected case with symptoms or for asymptomatic people who have a scheduled hospitalization in hospital or in Rsa.
Rapid antigenic test, on the other hand, as first choice in the case of those who have few symptoms and have not had contact with positives.
While when there are no symptoms "tests must be limited to close contacts of a confirmed case" and should not be prescribed also "contacts of contacts".
The document "Laboratory tests for SARS-CoV-2 and their use in public health", produced by the Ministry of Health and the Higher Institute of Health, clarifies how to organize the testing strategy in a homogeneous way throughout the territory.
In the light of the available evidence and the need to guarantee tests in times compatible with the needs of public health, we read in the interim Technical Note, prepared together with Inail, Technical Scientific Committee, Superior Health Council, Conference of Regions, National Federation of Medical Orders, Institute Spallanzani and the World Health Organization (WHO), "an appropriate choice among the available tests is essential".
In this regard, it should be noted, "it is not recommended to prescribe diagnostic tests in contact with close contacts in a confirmed case; if they are requested independently, subjects should not be considered suspicious or be subjected to any quarantine measures or reported to the Prevention Department, except for positive they must always be communicated ".
(HANDLE).